Ultrasound-guided Femoral Puncture to Reduce Access- Related Complications After TAVR: (ACCESS-TAVR SIRIO)
Transcatheter Aortic Valve Replacement
About this trial
This is an interventional treatment trial for Transcatheter Aortic Valve Replacement
Eligibility Criteria
Inclusion Criteria: Eligible Patients are male or female with severe aortic stenosis evaluated by the Heart Team as candidate to TAVR based on the current cardiology guidelines. Exclusion Criteria: Refusal to participate in the study; Inability to provide written consent to the study protocol; Chronic immuno-suppressant therapy; Any concomitant condition which, in the opinion of the Investigator, would not allow safe participation in the study (e.g., drug addiction, alcohol abuse, emotional/psychological disorder); Enrolment in another study that could confound the results of this study; Life expectancy < 1 year; Any contraindication to TAVR procedure; Non transfemoral TAVR.
Sites / Locations
- Fondazione Toscana Gabriele MonasterioRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
US-guided femoral puncture
Fluoroscopy-guided puncture
US-guided femoral puncture and Perclose ProGlide/Prostyle implantation during transcatheter aortic valve replacement (TAVR)
Fluoroscopy-guided puncture and Perclose ProGlide/Prostyle implantation during transcatheter aortic valve replacement (TAVR)